Department: Cancer Institute
Title:Associate Professor

Education & Professional Experience   Dr. Liang received his bachelor degree at jilin University in 2001.She received her Ph.D. degree of internal medicine at State key Laboratory for experimental hematology, Peking Union Medical College in 2006. After graduation, she joined in shanghai cancer institute as assistant professor and later associated professor. In 2013, she joined in Fudan University Shanghai Cancer Center as an associate professor and junior Principle Investigator at Cancer Institute.
Specialty   Non-coding RNAs, Hepatocellualr carcinoma
Research   Dr. Liang is majorly investigating function and mechanism of non-coding RNAs (microRNA and long non-coding RNAs) in hepatocellular carcinoma
Publication   Selected papers
1, Yu Zhang,*, Jian Yao,*, Lin Huan, Junwei Lian, Chuanyang Bao, Yan Li, Chao Ge, Jinjun Li, Ming Yao, Linhui Liang,†, Xianghuo He† GNAI3 Inhibits Tumor Cell Migration and Invasion and is Post-transcriptionally regulated by miR-222 in hepatocellular carcinoma. Cancer Lett (SCI,IF=5.019), 2015,356:978-984.
2,Liang L, Wong CM, Ying Q, Fan DN, Huang S, Ding J, Yao J, Yan M, Li J, Yao M, Ng IO, He X*. MicroRNA-125b suppressesed human liver cancer cell proliferation and metastasis by directly targeting oncogene LIN28B2. Hepatology. 2010, 52(5): 1731-1740. (IF= 10.84)
3, Ying Q*, Liang L*, Guo W, Zha R, Tian Q, Huang S, Yao J, Ding J, Bao M, Ge C, Yao M, Li J, He X*. Hypoxia-inducible microRNA-210 augments the metastatic potential of tumor cells by targeting vacuole membrane protein 1 in hepatocellular carcinoma. Hepatology. 2011, 54(6): 2064-2075. (IF=10.84)
4, Zheng B*, Liang L*, Huang S, Zha R, Liu L, Jia D, Tian Q, Wang Q, Wang C, Long Z, Zhou Y, Cao X, Du C, Shi Y*, He X*。MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene. 2012, 31(42):4509-16. (IF=7.216)
5, Liang L, He X*. Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy. Acta Pharmacol Sin. 2011, 32(11):1311-20. (IF=1.909)
6,Yao J*, Liang L*, Zhang Y, Ding J, Tian Q, Li JJ, He XH. GNAI1 Suppresses Tumor Cell Migration and Invasion and is Post-Transcriptionally Regulated by Mir-320a/c/d in Hepatocellular Carcinoma. Cancer Biology and medicine. 2012.9 (4): 234-241.
Awards   Shanghai medical science & technology Award in 2011
Out-patient Schedule